Levetiracetam
- Product NDC
- 31722-574
- Requested package NDC
- 31722-574-47
- 11-digit product format
- 317220574
- Labeler code
- 31722
- Product ID
- 31722-574_230b2750-8691-425b-9fe3-176b46e01e78
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Levetiracetam oral
- Dosage form
- SOLUTION
- Route
- ORAL
- Labeler
- Camber Pharmaceuticals, Inc.
- Application
- ANDA203052
- Marketing category
- ANDA
- Marketing start
- 2015-06-11
- Substance
- LEVETIRACETAM
- Active strength
- 100 mg/mL
- Pharmacologic classes
- Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 31722-574 | 31722-574-47 | E | Excluded after deficient or non-compliant submission was not corrected | excluded / ndc_excluded.zip | 367a005e9d99… | 383a685ebd0f… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A203052-001 | LEVETIRACETAM | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A203052-001 | AA |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 782e0a99824c… | |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 87673890dc5c… | |
| 2021-03-12 10:30 UTC | 2021-03 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 5aa47cf7b7d7… | |
| 2020-12-22 03:56 UTC | 2020-12 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 6a51e52b5d6a… | |
| 2024-02-18 07:12 UTC | 2024-02 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 1c564ffb4f44… | |
| 2023-12-20 04:57 UTC | 2023-12 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | ea1830bbd6c7… | |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | a72a2bbeb626… | |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 9b2671bbb829… | |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | a67488948f0b… | |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 3f0d92c62455… | |
| 2023-05-13 08:27 UTC | 2023-05 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 053a50430f4f… | |
| 2023-01-26 05:58 UTC | 2023-01 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 3bdfa0b2c4d7… | |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | 3a93d1ddd44b… | |
| 2022-10-28 04:53 UTC | 2022-10 | A203052-001 | LEVETIRACETAM | 100MG/ML | SOLUTION / ORAL | AA | 2013-02-28 | f41ea6bd6efb… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A203052-001 | AA | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A203052-001 | AA | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A203052-001 | AA | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A203052-001 | AA | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A203052-001 | AA | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A203052-001 | AA | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A203052-001 | AA | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A203052-001 | AA | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A203052-001 | AA | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A203052-001 | AA | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A203052-001 | AA | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A203052-001 | AA | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A203052-001 | AA | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A203052-001 | AA | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A203052-001 | AA | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A203052-001 | AA | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A203052-001 | AA | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A203052-001 | AA | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A203052-001 | AA | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A203052-001 | AA | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A203052-001 | AA | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A203052-001 | AA | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A203052-001 | AA | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A203052-001 | AA | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A203052-001 | AA | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A203052-001 | AA | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A203052-001 | AA | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A203052-001 | AA | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A203052-001 | AA | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A203052-001 | AA | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A203052-001 | AA | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A203052-001 | AA | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A203052-001 | AA | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A203052-001 | AA | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A203052-001 | AA | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A203052-001 | AA | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A203052-001 | AA | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A203052-001 | AA | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A203052-001 | AA | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A203052-001 | AA | 1 | f41ea6bd6efb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Levetiracetam
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| LEVETIRACETAM | 100 mg/mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| 44YRR34555 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 403884 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 0bc8468f-832c-4e71-95a2-db464d4d54bc | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 76e81f18-c6b9-f226-530a-a6296d5cd5f4 | Product name | 6 | 20251106 |
| 087c9486-f4a9-a565-c6fb-d6fa49f4572a | Product name | 6 | 20230317 |
| 525a8d4d-1988-fc3f-e292-27fd384de4f0 | Product name | 8 | 20230104 |
| 32b651f8-caa7-6882-11c7-54c4ad21796b | Product name | 8 | 20201216 |
| ce453ca5-90cf-41ed-9de4-de519f70a0f2 | Product name | 2 | 20160303 |
| d5e51f11-ad28-caa4-4b49-4143974782ad | Product name | 1 | 20150831 |
| 66666eb8-1fa6-4a60-bae9-e564e73b4cd5 | Product name | 1 | 20150728 |
| eecbc0ef-ab5c-4ff9-8aaa-6ea73ee46477 | Product name | 1 | 20150410 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 31722-574-47 | Levetiracetam | 473 mL in 1 BOTTLE | SOLUTION | 473 | 10 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 31722-574-47 | ML - Milliliter | 31722-574 | 75bf4d6b-15ea-42b1-acda-3ffa432c964c | 1 | 2013-07-02 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Levetiracetam Levetiracetam | LEVETIRACETAM | Atlantic Biologicals Corp. | 56fed03f-38c3-4273-8fd7-522bc508bf36 | 2026-07-27 | Warnings, Adverse reactions | 203052 ANDA203052 |
| Levetiracetam | LEVETIRACETAM | American Health Packaging | 3be7c30b-f35d-4dde-8bf8-24f67bd70865 | 2025-02-18 | Warnings, Adverse reactions | 203052 ANDA203052 |
| Levetiracetam | LEVETIRACETAM ORAL | Camber Pharmaceuticals, Inc. | 0bc8468f-832c-4e71-95a2-db464d4d54bc | 2024-08-03 | Warnings, Adverse reactions | 203052 ANDA203052 31722-574-47 31722-574 31722057447 |
| Levetiracetam | LEVETIRACETAM | Natco Pharma USA LLC | 34af3602-0188-4d2e-904b-2e40000bb45c | 2023-08-05 | Warnings, Adverse reactions | 203052 ANDA203052 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 403884 | levETIRAcetam 100 MG in 1 mL Oral Solution | PSN | 0bc8468f-832c-4e71-95a2-db464d4d54bc | 10 |
| 403884 | levetiracetam 100 MG/ML Oral Solution | SCD | 0bc8468f-832c-4e71-95a2-db464d4d54bc | 10 |
| 403884 | levetiracetam 100 MG per 1 ML Oral Solution | SY | 0bc8468f-832c-4e71-95a2-db464d4d54bc | 10 |
| 403884 | levetiracetam 1000 MG per 10 ML Oral Solution | SY | 0bc8468f-832c-4e71-95a2-db464d4d54bc | 10 |
| 403884 | levetiracetam 1500 MG per 15 ML Oral Solution | SY | 0bc8468f-832c-4e71-95a2-db464d4d54bc | 10 |
| 403884 | levetiracetam 500 MG per 5 ML Oral Solution | SY | 0bc8468f-832c-4e71-95a2-db464d4d54bc | 10 |
| 403884 | levETIRAcetam 100 MG in 1 mL Oral Solution | PSN | 3be7c30b-f35d-4dde-8bf8-24f67bd70865 | 8 |
| 403884 | levetiracetam 100 MG/ML Oral Solution | SCD | 3be7c30b-f35d-4dde-8bf8-24f67bd70865 | 8 |
| 403884 | levetiracetam 100 MG per 1 ML Oral Solution | SY | 3be7c30b-f35d-4dde-8bf8-24f67bd70865 | 8 |
| 403884 | levetiracetam 1000 MG per 10 ML Oral Solution | SY | 3be7c30b-f35d-4dde-8bf8-24f67bd70865 | 8 |
| 403884 | levetiracetam 1500 MG per 15 ML Oral Solution | SY | 3be7c30b-f35d-4dde-8bf8-24f67bd70865 | 8 |
| 403884 | levetiracetam 500 MG per 5 ML Oral Solution | SY | 3be7c30b-f35d-4dde-8bf8-24f67bd70865 | 8 |
| 403884 | levETIRAcetam 100 MG in 1 mL Oral Solution | PSN | 56fed03f-38c3-4273-8fd7-522bc508bf36 | 4 |
| 403884 | levetiracetam 100 MG/ML Oral Solution | SCD | 56fed03f-38c3-4273-8fd7-522bc508bf36 | 4 |
| 403884 | levetiracetam 100 MG per 1 ML Oral Solution | SY | 56fed03f-38c3-4273-8fd7-522bc508bf36 | 4 |
| 403884 | levetiracetam 1000 MG per 10 ML Oral Solution | SY | 56fed03f-38c3-4273-8fd7-522bc508bf36 | 4 |
| 403884 | levetiracetam 1500 MG per 15 ML Oral Solution | SY | 56fed03f-38c3-4273-8fd7-522bc508bf36 | 4 |
| 403884 | levetiracetam 500 MG per 5 ML Oral Solution | SY | 56fed03f-38c3-4273-8fd7-522bc508bf36 | 4 |
| 403884 | levETIRAcetam 100 MG in 1 mL Oral Solution | PSN | 9679202b-2208-43e5-841b-2faab0e516f3 | 1 |
| 403884 | levetiracetam 100 MG/ML Oral Solution | SCD | 9679202b-2208-43e5-841b-2faab0e516f3 | 1 |
| 403884 | levetiracetam 100 MG per 1 ML Oral Solution | SY | 9679202b-2208-43e5-841b-2faab0e516f3 | 1 |
| 403884 | levetiracetam 1000 MG per 10 ML Oral Solution | SY | 9679202b-2208-43e5-841b-2faab0e516f3 | 1 |
| 403884 | levetiracetam 1500 MG per 15 ML Oral Solution | SY | 9679202b-2208-43e5-841b-2faab0e516f3 | 1 |
| 403884 | levetiracetam 500 MG per 5 ML Oral Solution | SY | 9679202b-2208-43e5-841b-2faab0e516f3 | 1 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 31722-574-47 | 31722057447 | 473 mL in 1 BOTTLE (31722-574-47) | 473 ml | 2015-06-11 | 0000-00-00 | No | No | Current |